Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-11-355631
Filing Date
2011-12-29
Accepted
2011-12-29 16:15:33
Documents
4
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-K d275665d10ka.htm 10-K/A 100221
2 DIALYSIS ORGANIZATION AGREEMENT BETWEEN DAVITA INC. AND AMGEN USA INC. d275665dex1067.htm EX-10.67 2390764
3 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d275665dex311.htm EX-31.1 2490
4 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER d275665dex312.htm EX-31.2 2455
  Complete submission text file 0001193125-11-355631.txt   2497153
Mailing Address 1551 WEWATTA STREET 6TH FLOOR DENVER CO 80202
Business Address 1551 WEWATTA STREET 6TH FLOOR DENVER CO 80202 3034052100
DAVITA INC (Filer) CIK: 0000927066 (see all company filings)

EIN.: 510354549 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-14106 | Film No.: 111286834
SIC: 8090 Services-Misc Health & Allied Services, NEC